文献速递临床试验与 GCP基础与转化研究

通过细化运动处方重塑轻度认知障碍的病程:一项随机对照试验的研究方案,旨在理解运动促进认知功能的「是什么」「对谁」和「如何」

Reshaping the path of mild cognitive impairment by refining exercise prescription: a study protocol of a randomized controlled trial to understand the "what," "for whom," and "how" of exercise to promote cognitive function.
PubMed 文献 · Trials · 2022-09-09

该研究方案计划在社区居住的65至85岁轻度认知障碍(MCI)老年人中开展为期6个月、2×2析因设计的随机对照试验,共招募216名参与者,随机分为四组:平衡与 Tone(BAT)主动对照组、有氧训练(AT)联合抗阻训练(RT)组、AT联合BAT组、RT联合BAT组。主要结局为阿尔茨海默病评估量表-认知子量表-Plus测量的认知功能,次要结局包括认知功能、健康相关生活质量、躯体功能、活动记录仪指标、问卷和跌倒。研究旨在明确AT和RT各自及联合对MCI老年人认知功能的影响及潜在生物学机制。

要点

  • 该试验在MCI老年人中比较有氧训练、抗阻训练及其联合对认知功能的影响。
  • 主要结局采用阿尔茨海默病评估量表-认知子量表-Plus测量认知功能。
  • 结局在基线、6个月(试验完成)和18个月(12个月随访)时测量。

核心结论

  • 确立不同运动类型及组合对减轻认知衰退的效力,将提升以运动作为「药物」治疗MCI并延缓痴呆发生与进展的能力。

研究设计与样本

  • 为期6个月、2×2析因设计的随机对照试验,计划招募216名来自温哥华都会区的社区居住的65至85岁MCI老年人,按生物学性别分层随机。

主要发现

  • 参与者被随机分配到四组之一:每周4次平衡与Tone(BAT,主动对照);每周2次AT联合每周2次RT;每周2次AT联合每周2次BAT;或每周2次RT联合每周2次BAT。
  • 主要结局为阿尔茨海默病评估量表-认知子量表-Plus测量的认知功能;次要结局包括认知功能、健康相关生活质量、躯体功能、活动记录仪指标、问卷和跌倒。
  • 结局在基线、6个月(试验完成)和18个月(12个月随访)时测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Targeted exercise training is a promising strategy for promoting cognitive function and preventing dementia in older age. Despite the utility of exercise as an intervention, variation still exists in exercise-induced cognitive gains and questions remain regarding the type of training (i.e., what), as well as moderators (i.e., for whom) and mechanisms (i.e., how) of benefit. Both aerobic training (AT) and resistance training (RT) enhance cognitive function in older adults without cognitive impairment; however, the vast majority of trials have focused exclusively on AT. Thus, more research is needed on RT, as well as on the combination of AT and RT, in older adults with mild cognitive impairment (MCI), a prodromal stage of dementia. Therefore, we aim to conduct a 6-month, 2 × 2 factorial randomized controlled trial in older adults with MCI to assess the individual effects of AT and RT, and the combined effect of AT and RT on cognitive function and to determine the possible underlying biological mechanisms. METHODS: Two hundred and sixteen community-dwelling adults, aged 65 to 85 years, with MCI from metropolitan Vancouver will be recruited to participate in this study. Randomization will be stratified by biological sex and participants will be randomly allocated to one of the four experimental groups: (1) 4×/week balance and tone (BAT; i.e., active control); (2) combined 2×/week AT + 2×/week RT; (3) 2×/week AT + 2×/week BAT; or (4) 2×/week RT + 2×/week BAT. The primary outcome is cognitive function as measured by the Alzheimer's Disease Assessment Scale-Cognitive-Plus. Secondary outcomes include cognitive function, health-related quality of life, physical function, actigraphy measures, questionnaires, and falls. Outcomes will be measured at baseline, 6 months (i.e., trial completion), and 18 months (i.e., 12-month follow-up). DISCUSSION: Establishing the efficacy of different types and combinations of exercise training to minimize cognitive decline will advance our ability to prescribe exercise as "medicine" to treat MCI and delay the onset and progression of dementia. This trial is extremely timely as cognitive impairment and dementia pose a growing threat to global public health. TRIAL REGISTRATION: ClinicalTrials.gov NCT02737878 . Registered on April 14, 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Barha CK, Falck RS, Best JR, et al. Reshaping the path of mild cognitive impairment by refining exercise prescription: a study protocol of a randomized controlled trial to understand the "what," "for whom," and "how" of exercise to promote cognitive function. Trials. 2022. PMID: 36085237. doi:10.1186/s13063-022-06699-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。